Millennium Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.5M | Buy |
60,300
+30,300
| +101% | +$7.55M | 0.01% | 1884 |
|
|
2025
Q4 | $7.23M | Buy |
+30,000
| New | +$7.67M | ﹤0.01% | 2615 |
|
|
2025
Q2 | – | Sell |
-75,000
| Closed | -$16.8M | – | 6263 |
|
|
2025
Q1 | $16.8M | Buy |
75,000
+73,000
| +3,650% | +$17M | 0.01% | 1696 |
|
|
2024
Q4 | $457K | Sell |
2,000
-58,100
| -97% | -$14M | ﹤0.01% | 4822 |
|
|
2024
Q3 | $14.7M | Sell |
60,100
-89,100
| -60% | -$19.9M | 0.01% | 1846 |
|
|
2024
Q2 | $28.6M | Buy |
149,200
+46,900
| +46% | +$9.52M | 0.01% | 1195 |
|
|
2024
Q1 | $20.3M | Buy |
102,300
+87,300
| +582% | +$16M | 0.01% | 1547 |
|
|
2023
Q4 | $2.58M | Sell |
15,000
-208,900
| -93% | -$32.1M | ﹤0.01% | 3396 |
|
|
2023
Q3 | $33.1M | Buy |
223,900
+193,500
| +637% | +$35M | 0.02% | 1017 |
|
|
2023
Q2 | $6.64M | Buy |
+30,400
| New | +$6.78M | ﹤0.01% | 2398 |
|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$2.18M | – | 6971 |
|
|
2022
Q3 | $2.18M | Buy |
10,000
+7,000
| +233% | +$1.59M | ﹤0.01% | 3662 |
|
|
2022
Q2 | $629K | Sell |
3,000
-7,000
| -70% | -$1.49M | ﹤0.01% | 4770 |
|
|
2022
Q1 | $2.42M | Sell |
10,000
-5,000
| -33% | -$1.21M | ﹤0.01% | 3695 |
|
|
2021
Q4 | $3.91M | Sell |
15,000
-14,200
| -49% | -$3.68M | ﹤0.01% | 3146 |
|
|
2021
Q3 | $7.7M | Sell |
29,200
-10,800
| -27% | -$2.95M | ﹤0.01% | 2378 |
|
|
2021
Q2 | $9.86M | Buy |
40,000
+19,200
| +92% | +$4.04M | 0.01% | 1926 |
|
|
2021
Q1 | $4.04M | Sell |
20,800
-24,200
| -54% | -$4.85M | ﹤0.01% | 2815 |
|
|
2020
Q4 | $9.56M | Buy |
45,000
+35,000
| +350% | +$6.98M | 0.01% | 1786 |
|
|
2020
Q3 | $1.71K | Buy |
+10,000
| New | +$1.85M | ﹤0.01% | 2718 |
|
|
2019
Q2 | – | Sell |
-30,000
| Closed | -$3.12M | – | 4397 |
|
|
2019
Q1 | $3.12M | Buy |
+30,000
| New | +$3.1M | ﹤0.01% | 2092 |
|
|
2018
Q1 | – | Sell |
-20,000
| Closed | -$1.69M | – | 4012 |
|
|
2017
Q4 | $1.69M | Sell |
20,000
-180,000
| -90% | -$14.9M | ﹤0.01% | 2384 |
|
|
2017
Q3 | $15.4M | Buy |
200,000
+20,000
| +11% | +$1.53M | 0.02% | 948 |
|
|
2017
Q2 | $14M | Buy |
180,000
+170,000
| +1,700% | +$12.2M | 0.03% | 858 |
|
|
2017
Q1 | $720K | Sell |
10,000
-90,000
| -90% | -$6.22M | ﹤0.01% | 2583 |
|
|
2016
Q4 | $6.21M | Buy |
+100,000
| New | +$6.12M | 0.01% | 1187 |
|
|
2014
Q2 | – | Sell |
-4,800
| Closed | -$215K | – | 3793 |
|
|
2014
Q1 | $215K | Buy |
+4,800
| New | +$216K | ﹤0.01% | 3156 |
|
Other funds holding RMD
VCM
VPM
DAM
Millennium Management's RMD Position: Q1 2026 in Review
Millennium Management increased its ResMed (RMD) stake by 20% in Q1 2026, buying an estimated $5.94M and bringing the position to 142,280 shares worth $31.9M. The position accounts for 0.01% of the portfolio, ranked #1173.
Millennium Management first reported a position in RMD in Q2 2013 and has held it in 41 quarters since. The position peaked at $138M in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Millennium Management held 142,280 shares of ResMed worth $31.9M as of Q1 2026.
- Millennium Management bought 23,838 ResMed shares in Q1 2026, an estimated $5.94M.
- ResMed made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1173 holding.
- Millennium Management first reported a position in ResMed in Q2 2013 and has held it in 41 quarters since.
- Millennium Management's ResMed position peaked at $138M in Q2 2023.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.